Introduction
Continuous positive airway pressure (CPAP) is a commonly used therapy applied to an increasing range of clinical scenarios requiring ventilatory support. Apart from its use in acute congestive pulmonary oedema (ACPO), there are relatively few well-conducted studies demonstrating efficacy in terms of improvement in oxygenation in cases of acute respiratory failure not secondary to ACPO. [1] [2] [3] [4] [5] Nevertheless, in the acute setting, CPAP is often advocated and applied as part of the treatment of hypoxaemia associated with different aetiologies.
CPAP also has an important role in the treatment of obstructive sleep apnoea. The mechanism in this condition is different from that purported in the treatment of acute hypoxaemia. It is thus not the focus of this observational study.
While CPAP often improves oxygenation in respiratory failure, the mechanism by which this occurs is not clear. The major physical explanation is that the closed mask system used in CPAP delivers the set inspired oxygen concentration without air entrainment. This contrasts with most oxygen masks, where air entrainment dilutes the fractional inspired oxygen concentration, especially at higher respiratory rates associated with respiratory distress. In these circumstances, the oxygen delivery by mask deteriorates significantly. 6 Alternative or complementary physiological mechanisms, such as reduction in work of breathing, increased pulmonary compliance, reduction in pulmonary atelectasis or hydrostatic clearance of alveolar oedema by alteration of the Starling forces in the pulmonary capillaries, may also be relevant. 7, 8 These mechanisms are largely considered pressure-dependent.
The question is, whether the fundamental improvement in oxygenation frequently observed when changing from an open mask to a closed CPAP system occurs because of improved inspired oxygen delivery in the CPAP system or by the application of positive airway pressure. This was examined by using a simple lung model to assess the inspired oxygen concentration delivered with different breathing patterns using a CPAP system, a standard venturi mask and a Hudson mask, all of which are in common use in the ward environment. This was followed by the second part of the study, observing what happened when patients were changed from an open delivery system to a CPAP system to treat acute hypoxaemia. The standard protocol used in this institution was to start with an open, high flow CPAP circuit and when the patient acclimatised to the tight fitting mask, to add a 5 cm H 2 O positive airway pressure valve and then progress to 10 cm H 2 O.
Methods
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The second method was an observational study of the initiation of CPAP on patients diagnosed as being in acute respiratory failure, where CPAP was to be instituted by the medical staff and the Critical Care Outreach team. Ethics approval was sought from the Riverside Research Ethics committee, who advised that this should be considered as service evaluation. The protocol conformed to the written hospital protocol for introducing and monitoring CPAP in the ward environment and as it was deemed part of 'acute' care, the requirement for written consent was waived. Verbal permission from the patient was sought and documented.
Method 1: The lung model
This model system has been previously described. 6 It enables collection of mixed expired oxygen concentration from a manikin simulating spontaneous breathing, in effect giving the mean inspired oxygen concentration.
The experimental rig is shown in Figure 1 : 1. A Laerdal ® Airway Management Trainer manikin (Laerdal, ® Orpington, UK), was used to simulate the nasopharynx, larynx and trachea. A bellows was in effect the lung and was attached to the 'trachea' via a Y-piece. This bellows worked as a 'slave' bellows attached by a rod to a second 'driving' bellows, 2. The driving bellows were inflated by a ventilator (Dräger 900). As the driving bellows were inflated, they pulled open the slave bellows and thereby generated a negative pressure; this allowed 'inhalation' of air from the trachea and the mask on the manikin. On deflation of the driving bellows, the slave bellows emptied through the Y-piece. One-way valves directed the 'exhaled' gas into a 10 L acrylic plastic mixing chamber. The ventilator could be set to deliver a wide range of patterns of breathing which resulted in the reciprocal pattern in the slave bellows. Changes in respiratory rate, tidal volume, I:E ratio and maximum inspiratory flow rate were all possible. On passing through the mixing chamber, the oxygen concentration of the gas was measured via an in-line oxygen analyser (Datex-Ohmeda ™ 5120 Oxygen analyser (GE Healthcare, Chalfont St. Giles, UK)). This represented mixed expired gas and hence the mean inspired oxygen concentration. The analyser was calibrated to 100% and 21% as per the manufacturer' s instructions, and regularly checked. All elements of the system were connected with 50 cm segments of 22 mm corrugated tubing (Intersurgical, Wokingham, UK).
The CPAP system used was the same as that used clinically in this hospital both in ICU and the general wards. A flow generator (Whisperflow ® 2-60, Philips Respironics, Pittsburgh, PA, USA) was connected to the wall oxygen supply at 4 bar. The flow generator was connected to a specific CPAP system, consisting of 22 mm corrugated tubing (Intersurgical, Wokingham, UK), passing over a water bath humidifier (Fisher & Paykel, Maidenhead, UK) before joining a T-piece, which was inserted into a size 4 CPAP mask (Intersurgical Wokingham, UK). The expiratory limb from the T-piece had a further 100 cm of corrugated tubing attached, and then an A. The entire set up with the manikin attached via the trachea to the slave bellows, 2nd bellows. The drive bellows, 1st bellows, is inflated by the ventilator. On expiration the gas passes from the slave, (2nd) bellows to the mixing chamber through one way valves and the effluent is measured as the mixed expired oxygen concentration, which in a model must equal the real mean inspired concentration. B. The ventilator inflates the driving (1st) bellows which, by the connecting bar, pulls the slave (2nd) bellows open and 'breathes' in from the manikin. C. On deflation of the driving bellows, the slave bellows empties, exhaling into the mixing chamber. The mean expired oxygen is measured.
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attachable CPAP valve. Two levels of CPAP valve were used +5 cm H 2 O and +10 cm H 2 O (Accu-PEEP, Vital Signs, Barnham, UK). The CPAP mask was applied to the manikin using the standard harness. The flow rate on the generator was set to deliver at maximum, 140 L/min, according to the manufacturer' s specifications.
The in-built oxygen analyser on the flow generator and thus on the inspiratory limb of the system, was calibrated as per the manufacturer' s instructions. The experiments were performed at a FiO 2 of 0.6. The trial was run at a tidal volume of 500 mL, and the respiratory rates varied from 10, 15, 20 to 30 breaths/min. This was repeated with the Ventimask ® at an inspired O 2 of 0.6, with an oxygen flow rate of 15 L/min and with a Hudson mask at an oxygen flow rate of 6 L/min. The mean inspired oxygen values could be measured in the mixed expired gas.
Method 2. Patients in acute respiratory failure
These observations were carried out in patients in whom the decision to initiate the use of CPAP had been made by the medical team. As such, it conformed to protocol and was carried out in the general wards or intensive care.
When the decision to initiate CPAP for respiratory failure was made, the medical and nursing team involved in the patient care would notify the study team who would implement CPAP. Patients were recruited for observation if they fulfilled the following criteria: • Adults >16 years of age • Acute (<48 hours), type I respiratory failure: -PaO 2 <8.0 kPa when breathing room air -PaCO 2 <6.0 kPa • A decision to apply the CPAP system had been made by the attending physicians. They were not included in the observational study if any of the following were present: • Imminent endotracheal intubation • Patient delirium or low conscious level • Vomiting • Refusal by the attending physician.
The hospital protocol for initiating CPAP is shown in Table 1 . All clinical decisions relating to the patient' s ongoing care were made by the attending physicians and the observer had no influence on the delivery of care or any medical decisions beyond instituting CPAP. The standard protocol was followed (see Figure 2 ). The situation was explained and verbal permission sought. Baseline measurements were taken with the patient still on the Ventimask ® at a FiO 2 of 0.6 while the CPAP system was rapidly set up. It was then applied with the same inspired FiO 2 of 0.6, but with no pressure valve attached. Oxygen saturations were monitored. At 10 minutes the arterial blood gases were measured. Then a 5 cm H 2 O PEEP valve was attached so the CPAP was at 5 cm H 2 O and after 10 minutes further readings were taken. This was left in place if the blood gases were reasonable, for a further 50 minutes and another set of measurements taken. In some patients, a decision to increase CPAP was made by the attending team, and if so the valve was changed to a 10 cm H 2 0 valve, and again after 60 minutes measurements were taken. The features evaluated were the respiratory rate (RR) and, from the blood gases, the PaO 2 and PaCO 2 .
Comfort measurement
During the procedure the patients were asked at each stage to describe their level of comfort on a simple 0-10 scale, where 10 was the most comfortable.
System pressure measurement
As part of quality control, ten of the patients also had measurement of the pressure within the CPAP system. This was performed by simultaneously sampling the pressure within the inspiratory and expiratory limbs of the CPAP system, either side of the mask T-piece attachment using two 14G cannulae 
Data collection
Basic demographics and clinical diagnoses (as made by the attending physicians) were recorded. At each measurement point the arterial blood gases (ABG) were taken and the patients asked about for a comfort score (1-10).
Statistical analysis
All data were analysed using SPSS 18.0 (IBM, Portsmouth, UK). Where appropriate, data were analysed on an intentionto-treat basis. To detect statistically significant differences in oxygenation and respiratory rate between the different parts of the protocol, a two-way analysis of variance was performed with a Bonferroni correction to allow for multiple testing. Assessment of the ordinal data of the comfort score was performed using a Kruskal-Wallis test. Detection of location of differences was performed using repeat Mann-Whitney U tests. Analysis of demographic data, diagnosis and APACHE II score was performed using a Student' s t-test for continuous data and a Chi-square or Mann-Whitney U test for categorical data. Repeated measures analysis of variance were carried out as part of a sub-group analysis to look at whether age, gender, diagnosis or APACHE II score had additional influence on oxygenation. A p value of ≤0.05 was taken to represent a significant finding.
Sample size
An increase in PaO 2 of 2.5 kPa was considered clinically significant. A sample size of approximately 50 patients would be required to detect such an increase (significance 0.05 and a power of 80% (assuming a common σ of 6 kPa)).
Results
The lung model
The CPAP system was tested with a FiO 2 of 0.6 at a tidal volume of 500 mL and at rates of 10, 15, 20 and 30 breaths/min. There was no deterioration in performance as the respiratory rate increased. The CPAP system delivered oxygen at the expected FiO 2 , while there was a significant Table 3 Clinical diagnoses of aetiology of acute respiratory failure in study subjects. 
Respiratory rate (breaths/min)
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impairment of oxygen delivery with increasing respiratory rate with both other masks (Figure 3 ).
Patients in acute respiratory failure
Fifty-three patients in acute respiratory failure were observed during institution of CPAP. The demographic data are represented in Table 2 . This was an observational study and CPAP was instituted in a heterogenous group of patients with a wide range of causes for acute respiratory failure, see Table 3 . Three patients were unable to complete the study. Two of the patients were intolerant of CPAP prior to evaluation at one hour (stage 4). A further patient did not tolerate the increase to 10 cm H 2 O period (stage 5). One patient was intubated and ventilated during the period of observation. Fewer patients proceeded to the higher level of CPAP 10 cm H 2 O (n=31).
There was a significant rise in PaO 2 on changing from the Ventimask ® to the CPAP system without a valve (mean change 10.69 kPa, p<0.001). The effective pressure with high flow but no valve was 1.4 cm H 2 O (SD ± 0.4 cm H 2 O). The subsequent addition of the CPAP valve at 5 cm H 2 O made no further difference in PaO 2 . There was no increase in PaO 2 over the following 50 minutes, nor was there any subsequent improvement in PaO 2 with the application of the 10 cm H 2 O CPAP valve ( Table 4 and Figure 4 ). The mean value of PaCO 2
Oxygen system
Venturi was unaffected by either the change from Ventimask ® to the T-piece or on the application of the CPAP valve at either 5 cm H 2 O or 10 cm H 2 O (p=0.87) (see Figure 5 ). There was a statistically significant reduction in the respiratory rate over the period of two hours after the first application of the 5 cm H 2 O CPAP valve (p=0.04) (see Table 5 and Figure 6) .
The values for comfort scores are shown in Table 6 and Figure 7 , 10 being the most comfortable.
The comfort score was significantly reduced on the application of the CPAP system after the Ventimask, ® median score of 9 dropping to a median of 7 (p=0.047). The reduction in the comfort score across the whole time period was statistically significant, median 7 to median of 4 (p<0.001, Kruskal-Wallis test); differences between stages were not apparent. There was obvious discomfort that seemed to increase with both time and the 10 cm H 2 O CPAP valve.
Discussion
This simple observational study evaluated the changes in oxygenation and respiratory rate when changing from a Ventimask ® with a FiO 2 of 0.6, to a CPAP system at 0, 5 and 10 cm H 2 O.
Initially tested on a lung model, the CPAP system consistently delivered the inspired oxygen concentration as set, despite increasing respiratory rates. That was not the case with either the Ventimask ® or the Hudson mask and the inefficiency of their oxygen delivery deteriorated at higher respiratory rates that might be seen in acute respiratory failure. These findings mirror those found in a previous publication. 6 This is not surprising, as with higher respiratory rates entrainment of air is likely with mask systems, but prevented with a closed CPAP system.
In patients with acute type I respiratory failure, there was a significant increase in oxygenation on changing from a Ventimask ® to a CPAP system despite no change in the set fractional inspired oxygen. The subsequent addition of pressure of either 5 cm H 2 O or 10 cm H 2 O appeared to have no immediate further benefit on oxygenation, but did result in a reduction in respiratory rate. These are interesting findings.
The rapid improvement in oxygenation, similar to those seen in the model, would tend to support the idea that effective oxygen delivery is higher with a CPAP system than with open masks, even the Venturi. If so, the increase in oxygenation seen in type I respiratory failure treated with CPAP is primarily due to improvement in oxygen delivery through the system rather than the more physiological explanation based on cardiorespiratory mechanics. This is also supported by the lack of obvious increase in oxygenation when a valve was added at either 5 or 10 cm H 2 O. 
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The observed reduction in respiratory rate also took place over a relatively short time course but it was somewhat longer than that seen with changes in oxygenation. There could be several possible reasons for this. It may reflect the correction of relative hypoxaemia influencing central drive and hence breathing pattern. Alternatively, it could be due to alterations in workload in association with changes in pulmonary compliance. Patients were undergoing concurrent medical therapy other than just oxygen delivery and improvements in oxygenation may reflect clinical improvement for other reasons. There is clearly a difference in the time course for improvement in oxygenation and for reduction in respiratory rate. It is possible that the former reflects the efficiency of the system, physics, while the latter indicates more physiological changes associated possibly with lung compliance and work of breathing.
The intrinsic pressure of the system even with no valve may play a part, but a mean measured pressure change of 1.4 cm H 2 O (SD ± 0.4) seems highly unlikely to cause such immediate improvement in oxygenation, particularly as further increases of positive airway pressure did not result in improvement in PaO 2 .
There was no obvious effect on carbon dioxide clearance. The other, more subjective, measure was comfort. It was clear that patients found CPAP uncomfortable and this increased with time.
There are several limitations to these observations. Firstly, the short duration of observation sought to follow the immediate changes seen with instituting CPAP. One to two hours should be long enough for CPAP to effect a change in the measurements chosen. This was shown by Bersten et al, who documented that in patients with pulmonary oedema, PaO 2 levels increased with CPAP at 30 minutes but at 24 hours were the same as in the mask oxygen group. 9 The decrease in respiratory rate with CPAP was seen within this short timescale, although this was longer than has been documented in the literature with pulmonary oedema. 4, 9, 10 Secondly, few of these patients had ACPO, which was the classical indication for CPAP. Yet in most hospitals, the use of CPAP both in the wards and intensive care has extended well beyond its original indications and hence observing its use in acute respiratory failure in more general circumstances is important and relevant. Curiously the very few patients with ACPO seemed to behave in a similar way to those without.
Thirdly, in order to try to observe the effects of CPAP it was essential to restrict observations to those patients where other confounders such as level of consciousness might influence findings. Similarly, including those patients where CPAP was clearly a short-term bridge to ventilation was not appropriate. Many patients circumvent CPAP and go to bi-level noninvasive ventilation and as this was intended to assess the benefits of CPAP, that population was not included.
A further issue is that despite the venturi system being used as per the manufacturer' s instructions, there is a caveat in their literature regarding oxygen flow rates with this system in patients who are hyperventilating. This suggests increasing the oxygen flow rate in such cases. It is possible that increasing the oxygen flow rate above 15 L/min would result in less improvement in oxygenation between the two systems, but as most ward-based flowmeters are only scaled to 15 L/min this was not tested.
As the entrainment of air through the valve is linearly related to the oxygen flow rate, and for a 0.6 valve this is only 14-15 L/min at a 15 L/min oxygen flow rate (total gas flow 30 L/min), the chances of achieving the desired total gas flow to match a peak inspiratory flow rate of what could be in excess of 250 L/min, are minimal without a high flow oxygen generator. What was needed for this study was an initial open oxygen delivery device that could reliably deliver the same FiO 2 as that 'dialled up' on the CPAP system (0.6). It was felt that initial changes in PaO 2 would thus be as a response to the change in the method of oxygen delivery, permitting the ongoing assessment of the effect of the positive airway pressure.
Finally, the comfort findings could have potentially been different if a different CPAP system had been selected, for example a Boussignac system which uses the Bernoulli effect to create a virtual valve and thus obviates the need for an entirely closed system. The system and setup chosen for this study was that which was in use in the institution and is a more common application in general. A similar examination of other CPAP systems would be valid. It is of note that the Boussignac system still requires a sealed mask and harness which could still be subject to many of the comfort issues seen with the Whisperflow ® system, despite better communication and hygiene access.
Several questions are generated from these observations. There is little doubt that CPAP has several effects, but part of the reason that it has become a therapeutic panacea may be the rapid improvement in oxygenation resulting from its use. The accepted mechanism of this improvement has been couched in terms of compliance, recruitment and work of breathing. The observed changes in respiratory rate may support this in part, but the speed and magnitude of the changes in oxygenation make it more likely that the real mechanism is more reliable delivery of the set inspired oxygen concentration. In patients with respiratory failure, rising respiratory rates and changes in peak flows increase the likelihood of air entrainment in open systems and hence, as patients get sicker, oxygen delivery becomes less efficient. Changing to CPAP immediately increases effective oxygen delivery and hence provides an instantaneous response in oxygenation.
These observations need further investigation. The principle problem with pressurised systems is discomfort, which is recognised as a major issue, but is also accompanied by a lack of access for food, drink, hygiene and physiotherapy. If the benefit is oxygen concentration and pressure is less important than we thought, then it might be possible to look at more patient-friendly ways of achieving oxygen delivery.
Conversely, the heterogeneity of the patients may indicate that CPAP as a general treatment is inappropriate and should be confined to those in whom there is definite benefit. That will require study of different diagnostic groups and ascertaining the benefit of CPAP.
Conclusion
In a lung model, the consistency of oxygen delivery with a closed CPAP system is superior to that delivered by a standard oxygen mask, especially as the respiratory rate rises as seen in patients with respiratory failure. This is because of air entrainment at peak flows with the open systems. In patients in acute respiratory failure, changing from a Ventimask ® at the same set inspired oxygen fraction, to CPAP, rapidly achieves a higher inspired oxygen concentration even before the system is pressurised. Oxygenation improvement does not increase with incremental pressure. Added pressure does however result in a reduced respiratory rate. In this simple observational study, it appears the immediate effect of CPAP on oxygenation in patients is independent of pressure. These observations challenge existing concepts of how CPAP works in respiratory failure.
